FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto) is the Life Science AI Business Headquarters.^■Koichi Kawabuchi (hereinafter referred to as Professor Kawabuchi), a professor in the field of health economics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, has been appointed as an advisor.

Professor Kawabuchi has been involved in medical economics for many years, and analyzes various phenomena that occur in the medical field such as medical policy such as the medical insurance system and medical management using economics methods to create a sustainable society. We have a wealth of knowledge to realize this.

Through this appointment as an advisor, FRONTEO will ask Professor Kawabuchi for advice from a strategic perspective in the development of the life science AI business. Through data analysis using the AI ​​engine Concept Encoder originally developed by FRONTEO, we aim to realize and popularize diagnosis and nursing support, shortening and improving accuracy of the drug discovery process, and cost optimization.

* As of January 2020, 1, the name of the Healthcare Business Headquarters was changed to the Life Science AI Business Headquarters.

Biography: Koichi Kawabuchi Professor, Department of Health Economics, Tokyo Medical and Dental University

He graduated from Hitotsubashi University Faculty of Commerce in 1983 and received a Master of Business Administration (MBA) from the University of Chicago School of Business in 1987.After working at a private hospital and company, worked at the National Institute of Public Health and Hospital Management (now the National Institute of Public Health) Health Economics Research Department from 1989 to 1998 (Senior Researcher since 95). He retired from the Ministry of Health and Welfare in 98, and in April of the same year, he concurrently served as a professor at the Faculty of Economics, Nihon Fukushi University, a senior researcher at Nihon Fukushi University, a faculty fellow at the Ministry of Economy, Trade and Industry, and a visiting researcher at Stanford University. He has been in his current position since April 4.In addition, he is also a visiting professor at Japan-China Friendship Hospital, an emeritus professor at Shenyang Medical School, a visiting professor at Ningxia Medical University, and a special member of the China Health Industry Magazine Special Committee.

Social activities, committee members, directors, etc .:
Councilor / Director of Japan Medical and Hospital Management Association, Councilor of Japan Clinical Path Society, Chairman of Replet Fund Business Foundation, Director of Japan Care and Welfare Management Human Resources Education Association, Public Interest Incorporated Association Medical / Hospital Management Standing Director of Research Association

Main books:
"Does the landscape change? 2040 Pharmacy (Yakuji Nippo Co., Ltd., 2016)" "Key to the success of the comprehensive community care system (Japan City Center, 2015)", "Visualization" medical care "Introduction to Economics (Medical and Dental Publishing Co., Ltd., 2014)", "National Insurance Can Still Be Saved (Free Studio, 2011)", "Is Medical Regeneration Possible (Chikuma Shinsho, 2008)", "Hospital Dignity (Japan Medical Planning, 2008) ”etc.

concept encoderabout　URL: https://www.fronteo.com/products/conceptencoder/
Concept Encoder is an artificial intelligence (AI) developed by FRONTEO specifically for the healthcare industry.It was developed in 2018 with the aim of effectively analyzing and utilizing big data related to healthcare, which includes a large amount of free-form text data, based on evidence.We have introduced and realized statistical methods such as the significance test, which is indispensable for "evidence-based medicine (EBM)", which is a common understanding among healthcare professionals, in natural language analysis. Concept Encoder can also be co-analyzed with data other than text, and we are conducting research on co-analysis with "numerical data" such as gene expression information, vitals and various test values ​​accumulated in the healthcare field.Patent registration number: Patent No. XNUMX

FRONTEOabout　URL: https://www.fronteo.com/
FRONTEO Inc. has developed its own artificial intelligence engine "KIBIT".^®(Kibit) ”and“ concept encoder^®(Concept encoder) ”is a data analysis company that supports information analysis such as big data.Established in August 2003 as a company that supports e-discovery (electronic discovery), which preserves, investigates, and analyzes electronic data necessary for international litigation, and digital forensic investigations.In-house developed data analysis platform "Lit i View"^®(Lit Eye View) ”,“ Predictive Coding Predictive Coding^®(Predictive Coding) ”technology is used to provide legal proceedings support to companies.The unique artificial intelligence-related technology cultivated and developed in this legal business learns "tacit knowledge" such as expert experience and intuition, and realizes prediction of future behavior from analysis of human thoughts.We have expanded into areas such as life science and business intelligence, and have achieved results in "work style reform" in addition to FinTech and RegTech. Listed on TSE Mothers on June 2007, 6 and NASDAQ on May 26, 2013.The capital is 5 thousand yen (as of March 16, 2,559,206). As of July 2019, 3, the company name has been changed from UBIC Co., Ltd. to the current company name.